Orchid Ventures Inc ORVRF

Psychedelics as Medicine

[mikstock]

These other companies could be well exposed to the psychedelic medicine market, which these could be worth around $100 billion. There are several reasons why this could happen. Spare some time on looking the possibilities that psychedelics prepared for you here. Sponsored post

 

It was said that the US FDA appears to be supportive of psilocybin research. In 2018, for example, the agency recognized psilocybin as a potential “breakthrough therapy” for depression. Clinical studies from prestigious institutions and New York University appear to already be showing positive results.

 

Even state and local governments also appear to be accepting its usage as well. Check disclaimer on profile and landing page.